Innovating Kidney Trials: PROMs, New Designs, and Global Roadmaps

29 Mar 2026 3:50 p.m. 4:50 p.m.
311 - 312
MasaomiNangaku Chair Japan
Session description: This session reviews key outcomes from the ISN PARADIGM consensus meeting(link), highlighting advances in trial design, patient-reported outcomes, and composite endpoints. Speakers will reflect on progress since the meeting and outline priorities for the next phase of kidney research.
Learning objectives:
1.Learn the main PARADIGM recommendations.
2.Understand recent advances in trial design and outcome measures
3.Explore future priorities for global kidney research
Time Session
3:50 p.m.
3:52 p.m.
Opening & Session Overview
AdeeraLevin Speaker Canada
3:52 p.m.
4:02 p.m.
Overcoming the Bottleneck- Endpoints in Phase 2 Trials
Kai-UweEckardt Speaker Germany
4:02 p.m.
4:12 p.m.
Integrating Patient-Reported Outcomes (PROMs)
AllisonJaure Speaker Australia
4:12 p.m.
4:22 p.m.
Innovating with New Trial Designs
MegJardine Speaker Australia
4:22 p.m.
4:32 p.m.
Using Hierarchical Composite Endpoints (HCEs)
HiddoLambers Heerspink Speaker Netherlands
4:32 p.m.
4:47 p.m.
Panel Discussion & Q&A
4:47 p.m.
4:50 p.m.
Closing Remarks
MasaomiNangaku Speaker Japan